News

Access and download our newsletters from the Newsletter Archive

 
 

As well as keeping you up to date with the latest developments within the life sciences sector, Bionow members can also post updates to the Bionow News page to promote themselves to over 300 Bionow member organisations and the UK Life Sciences sector.

Whether currently a member or not, keep up to date with all the latest news and events by registering to receive the Bionow newsletter.

Iksuda Therapeutics announces first patient dosed in Phase 1 trial of IKS014 in patients with advanced solid tumours that express HER2

Expanded agreement grants Iksuda access to Legochem Biosciences’ next generation ADC platform for up to six targets. Iksuda also gains access to LegoChem Biosciences’ new payload, supple...

IKS01 shows marked anti-tumour efficacy in pre-clinical models of ovarian and lung cancer. Data to be presented 28th September 2019 at ESMO Congress in Barcelona, Spain

Agreement gives Iksuda access to Femtogenix’s therapeutic payloads to advance lead ADC for difficult-to-treat solid tumours

Sign up to our Newsletter

Subscribe

* indicates required

Our Valued Sponsors & Partners